Covid-19 Test Kit
GET INSTANT COVID TEST RESULTS IN 20 MINUTES
New variants have shown that anyone can be vulnerable to COVID-19 even if they are vaccinated or young.
With rapid antigen testing, you can test yourself after being out in public. Early and regular testing helps you better care for yourself and protects your friends, family, and community members from potential exposure.
For illustration purposes only
EASY STEPS TO COMPLETE YOUR TEST
SWAB
Brush against the inner wall of both nostrils 5 times each in a circular motion with a non-invasive nasal swab. Our nasal swab is soft, highly absorbent, and only needs to be inserted ½ - ¾ inches so you can test yourself comfortably.
DIP
Insert the swab with the sample into the bottom of the tube and stir it in the fluid 15 times. Squeeze the sides of the tube around the swab as you pull it out.
DRIP
Put 3 drops of the mixed solution onto the sample port of the COVID-19 test card.
RESULT
Add drops to reader and start the timer. Your results will be ready in 15 minutes.
Easy To Read Test Results
“For illustration purposes only. Please refer to package inserts for manufacturer instructions on how to use each medical device”
Your rapid COVID test results appear on the reader after 15 minutes, similar to a pregnancy test.
Recommended for you
Other Covid-19 Rapid Test Kit
Quidel
Quidel Quickvue® At-Home OTC Antigen Test (25 pack, $17/test)
$425.00
Fast. Easy. Ready When You Are.
QuickVue At-Home OTC COVID-19 Test lets you get rapid results, in the privacy of your own home. This antigen test is available over-the-counter, everything you need is in the package and taking the test is simple.
The test is intended for the qualitative detection of the nucleocapsid proteins from SARS-CoV-2 from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 36 hours between tests
How To Use: 1. Swab - Collect a gentle nasal swab sample. 2. Swirl - After adding the swab to the solution tube. 3. Dip - Put the strip into the tube. 4. Read Results - Straightforward and easy-to-read results
Easy-to-use at-home COVID-19 testing kit provides results in just 10 minutes; non-invasive design makes it easy to gently swab your nose, place in pre-filled tube, and quickly get rapid test results; FDA Emergency Use Authorized and FSA/HSA eligibleCOVID-19.
Home COVID-19 test is quick, simple and designed for self-collected nasal swabs, ages 14 or older; Ages 2+ can be tested if adult collects sample; straightforward results with pink or blue line on test strip.
At-home COVID-19 screening is for those with or without symptoms and takes approximately 10 minutes; this listing is for 25 tests.
Serial testing is when one person tests themselves multiple times for COVID-19 on a routine basis, such as every day or every other day. By testing more frequently, you may detect COVID-19 more quickly and reduce spread of infection.
The test is intended to be read at 10 minutes.
This test kit does not provide a document to present for certain uses, including air travel, re-entry requirements, or testing programs. Please check the requirements for your specific testing needs
Each kit includes: 25 individually-wrapped sterile foam swabs in order to test twice over 3 days with at least 24-36 hours between tests, pre-filled tubes (no measuring/counting drops), tube holder, instruction sheet, patient fact sheets
In a clinical study, the QuickVue at Home OTC Covid-19 test identified positive cases 83.5% of the time, and identified negative cases 99.2% of the time
The Quickvue At-home Otc COVID-19 Test is manufactured in the USA by Quidel Corporation and was approved by Health Canada on August 26, 2021.
BTNX
BTNX Rapid Response (5 Pack)
$59.99
The 5 Pack of BTNX Rapid Response® antigen tests is the perfect screening tool for COVID-19.
Put your mind at ease with a 5-pack of BTNX Rapid Response® COVID-19 Antigen Rapid Test Device. It is an efficient, accurate, and reliable method of testing. It is easy to use and delivers results within 15 minutes!
The BTNX Rapid Response™ COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal secretion samples.
Package Contents:
5 Test cassettes
5 Individually packed swabs
5 individually packed buffers
5 tubes and nozzles
1 Tube stand
1 Product insert
Intended Use
The Rapid Response(TM) COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset and from individuals without symptoms or other epidemiological reasons to suspect COVID-19 infection, when tested twice over two (or three) days with at least 24 hours (and no more than 36 hours) between tests. This test is authorized for use at the Point of Care i.e., in patient care setting.
Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigens are generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities.
Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed witha molecular assay, if necessary, for patient management.
The Rapid Response(TM) COVID-19 Antigen Rapid Test Device is intended for use by trained laboratory personnel or health care professionals.
By purchasing this product, you agree to follow the manufacturer’s intended use for this product.
Weight
0.05 lbs
Test Technology
Antigen
Diagnostic Sensitivity
78.6% - 96.2%
Diagnostic Specificity
96.5% - 100%
Shelf Life (expiration)
12-18 months
Storage Temperature
2-30°C/36-86°F
Time to Result
15 minutes
Sample Collection
Shallow nasal
Roche
Roche Sars-Cov-2 Rapid Antigen Test (25 pack, $13/test)
$325.00
The Roche SARS-CoV-2 Rapid Antigen Test is a reliable, rapid chromatographic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2 present in the human nasopharynx.
This test is an aid in detecting antigens from the SARS-CoV-2 virus in individuals suspected of COVID-19. This product is strictly intended for professional use in by trained individuals.
The kit is ready for use and contains all equipment needed to perform a test. The following components are needed for a test and included in the kit:
Test device (individually in a foil pouch with desiccant)
Extraction buffer tube
Nozzle cap
Sterile swabd
Film (can be attached to the test device when performing outdoor testing)
Instructions for use
Quick Reference Guide
Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worker.
By purchasing this product, you agree to follow the manufacturer’s intended use.
Note: Images are for reference only. Actual product packaging may vary.
BTNX
BTNX Rapid Response (25-pack)
$275.00
The Rapid Response™ antigen test device is the perfect screening tool for organizations that want to try to protect their workplace from the risk of COVID-19 lockdowns.
Used as part of a comprehensive rapid testing program for COVID-19, the BTNX nasal device offers fast, easy-to-use, and reliable screening. Testing all staff 1-2 times/week will help detect the virus early and decrease the likelihood of spreading COVID-19.
Rapid Response® COVID-19 Antigen Rapid Test Device. It is an efficient, accurate, and reliable method of testing that can be used by any healthcare professional. It is easy to use and delivers results within 15 minutes!
The BTNX Rapid Response™ COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal secretion samples.
Intended Use
The Rapid Response™ COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point ofCare i.e., in patient care settings.
Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigens are generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status.
Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities.
Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patientmanagement.
The Rapid Response™ COVID-19 Antigen Rapid Test Device is intended for use by trained laboratory personnel or health care professionals.
By purchasing this product, you agree to follow the manufacturer’s intended use.
Test Technology
Antigen
Diagnostic Sensitivity
78.6% - 96.2%
Diagnostic Specificity
96.5% - 100%
Shelf Life (expiration)
6-18 months
Storage Temperature
2-30°C/36-86°F
Time to Result
15 minutes
Sample Collection
Shallow nasal